middle.news
How Will Genetic Technologies Rebuild After geneType Sale and Administration?
8:36pm on Friday 29th of August, 2025 AEST
•
Healthcare
Read Story
How Will Genetic Technologies Rebuild After geneType Sale and Administration?
8:36pm on Friday 29th of August, 2025 AEST
Key Points
Entered voluntary administration in November 2024 after failed capital raise
Sold geneType business and assets to Rhythm Biosciences for $625,000
Delisted from Nasdaq in December 2024 due to administration status
Cash position at $1.01 million with net quarterly outflows of $0.61 million
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Genetic Technologies (ASX:GTG)
OPEN ARTICLE